ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Report Urges Stronger NCI Nutritional research

December 10, 1999

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

Funding Opportunities; Program Announcements Released By NCI

May 21, 1999